Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/B 5.89
FBT's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. FBT: 5.89 )
Ranked among companies with meaningful P/B only.
FBT' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 6.17
Current: 5.89
0
6.17

Buy Back

vs
industry
vs
history

More Statistics

Short Percentage of Float0.00%
52-Week Range $78.18 - 114.62
Shares Outstanding (Mil)8,700,002.00
» More Articles for FBT

Headlines

Articles On GuruFocus.com
Gurus Invest in Profitable Restaurant Companies Sep 23 2016 
LivaNova Growing Through New Medical Devices Sep 23 2016 
Why CVS Offers an Attractive Investment Opportunity Sep 23 2016 
Companies in Energy Sector Among Undervalued Growth Stocks Sep 23 2016 
RS Management Increases Position in Ingevity Sep 23 2016 
Should You Invest for Dividends Now or Later? Sep 23 2016 
Paul Tudor Jones Purchases Stake in Visa Sep 23 2016 
Despite Setbacks, Deere Will Recover Sep 23 2016 
Illinois Tool Works Looks Strong Sep 23 2016 
Dr Pepper Snapple Is Primed to Grow Sep 23 2016 

More From Other Websites
How Ionis Pharmaceuticals’ Valuation Compares to Its Peers Sep 20 2016
Sarepta Stock Surge Boosts Some Biotech ETFs But Not Others Sep 19 2016
Inside the Recent Surge in Biotech ETFs Sep 14 2016
Technicals, Politics Clash for Biotech ETFs Sep 06 2016
How Is Incyte’s Only FDA-Approved Drug Performing? Sep 05 2016
Clinton's Proposal To Combat Drug Price Hikes Sep 02 2016
Biotech ETF Industry Outlook Aug 31 2016
Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns Aug 31 2016
United Therapeutics Makes Novel Technologies a Priority Aug 31 2016
Biotech ETFs Back In The Spotlight Aug 30 2016
What Should We Expect from BioMarin’s Kuvan in 2016? Aug 26 2016
What’s BioMarin’s Expected Revenue Growth in 2016 and 2017? Aug 25 2016
Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock? Aug 24 2016
How Xtandi Fueled Big Pharmaceutical Interest in Medivation Aug 24 2016
Another Endorsement for Biotech ETFs Aug 16 2016
Biotech Breakout: Take 3 Aug 04 2016
Big Biotech Buyout Banter Buoys IBB Aug 02 2016
How Much Will BioMarin’s Kuvan Fetch in 2Q16? Aug 02 2016
What’s behind the Recent Fall in Alexion’s Valuation Multiple? Jul 25 2016
How Much Will Orkambi Fetch for Vertex Pharmaceuticals in 2Q16? Jul 22 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK